Jubel Axel, Andermahr Jonas, Schiffer Gereon, Fischer Jürgen, Rehm Klaus E, Stoddart Martin J, Häuselmann Hans J
Eduadus Hospital, Cologne, Germany.
Am J Sports Med. 2008 Aug;36(8):1555-64. doi: 10.1177/0363546508321474.
New cell-based treatments for articular cartilage repair are needed. As the optimal scaffold for cartilage repair has yet to be developed, scaffold-free cartilage implants may remove the complications caused by suboptimal scaffolds.
The implantation of a scaffold-free, autologous de novo cartilage implant into standardized full-thickness cartilage defects of femoral condyles in sheep leads to a qualitatively better regenerative tissue than does periosteal flap alone or no treatment.
Controlled laboratory study.
Chondral defects 4 mm in diameter (1 per sheep) were created in the center of 1 medial femoral condyle of 48 sheep. Twelve defects were allowed to heal spontaneously, 16 defects were covered with periosteal flaps alone, and 20 defects were filled with autologous de novo cartilage graft and overlaid with a periosteal flap. Differences were assessed macroscopically using the International Cartilage Repair Society score and microscopically using the International Cartilage Repair Society histological score and Mankin score at 26 and 52 weeks.
The results of the International Cartilage Repair Society Cartilage repair assessment showed that the transplant group was better than was the untreated control at both time periods but not significantly different than was the periosteal flap group. Implanted groups demonstrated a marked improvement in grade of defect filling, cartilage stability, cell distribution, and matrix assessments in each method of assessment. In the transplant group, 2 defects were filled with hyaline cartilage, 5 with mixed hyaline and fibrocartilage, and 2 with fibrocartilage alone.
Chondral defects treated with de novo cartilage transplantation show qualitatively better microscopic and macroscopic regeneration than do those treated with periosteal flaps alone.
Results of the current study show that third-generation autologous chondrocyte transplantation is a promising development in the field of biologic cartilage regeneration. Future studies should compare this technique with the original Brittberg technique.
需要新的基于细胞的关节软骨修复治疗方法。由于尚未开发出用于软骨修复的最佳支架,无支架软骨植入物可能会消除由欠佳支架引起的并发症。
将无支架的自体新生软骨植入物植入绵羊股骨髁标准化全层软骨缺损处,与单独使用骨膜瓣或不进行治疗相比,能产生质量更好的再生组织。
对照实验室研究。
在48只绵羊的1个内侧股骨髁中心制造直径4毫米的软骨缺损(每只绵羊1个)。12个缺损让其自行愈合,16个缺损仅覆盖骨膜瓣,20个缺损填充自体新生软骨移植物并覆盖骨膜瓣。在26周和52周时,使用国际软骨修复协会评分进行宏观评估,使用国际软骨修复协会组织学评分和曼金评分进行微观评估。
国际软骨修复协会软骨修复评估结果显示,移植组在两个时间段均优于未治疗的对照组,但与骨膜瓣组无显著差异。在每种评估方法中,植入组在缺损填充等级、软骨稳定性、细胞分布和基质评估方面均有显著改善。在移植组中,2个缺损填充透明软骨,5个填充透明软骨和纤维软骨混合物,2个仅填充纤维软骨。
与仅用骨膜瓣治疗的软骨缺损相比,新生软骨移植治疗的软骨缺损在微观和宏观再生方面质量更好。
本研究结果表明,第三代自体软骨细胞移植是生物软骨再生领域一项有前景的进展。未来研究应将该技术与原始的布里特伯格技术进行比较。